• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促肾上腺皮质激素释放因子家族及其受体:外周的促炎或抗炎靶点?

Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?

机构信息

Department of Haematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

出版信息

Inflamm Res. 2011 Aug;60(8):715-21. doi: 10.1007/s00011-011-0329-2. Epub 2011 Apr 8.

DOI:10.1007/s00011-011-0329-2
PMID:21476084
Abstract

The corticotropin-releasing factor (CRF) family of neuropeptides is composed of CRF, urocortin 1 (UCN 1), UCN 2 and UCN 3, which can bind to CRF-binding protein (CRF-BP) and two known receptors, CRFR1 and CRFR2, to perform many pathophysiological functions, including inflammation. In contrast to its anti-inflammatory effect in the central nervous system, the roles of the CRF family and its receptors in the periphery are diverse. However, the biological activities of the CRF family in inflammation are circumstantial and remain controversial. It is suggested that this diverse effects of the CRF family may be due to the different types of CRF receptors, different cells and tissues and even different concentrations of CRF family peptides. Though there are difficulties or limitations in establishing the exact modulatory roles of the CRF family and its receptors in peripheral inflammation, the application of CRF receptor agonists or antagonists to treat inflammatory diseases is being pursued with increasing interest. This review describes the effects and mechanisms of the CRF family and its receptors in inflammation; the possible application of CRF receptor agonists or antagonists in inflammatory diseases or disorders will also be discussed.

摘要

促肾上腺皮质释放因子(CRF)家族的神经肽由 CRF、孤啡肽 1(UCN1)、UCN2 和 UCN3 组成,它们可以与 CRF 结合蛋白(CRF-BP)和两种已知的受体 CRFR1 和 CRFR2 结合,从而发挥许多生理病理功能,包括炎症。与 CRF 家族在中枢神经系统中的抗炎作用相反,其在外周的作用是多样化的。然而,CRF 家族在炎症中的生物学活性是偶然的,仍然存在争议。据推测,CRF 家族的这种多样化作用可能是由于不同类型的 CRF 受体、不同的细胞和组织,甚至 CRF 家族肽的不同浓度所致。尽管在确定 CRF 家族及其受体在外周炎症中的确切调节作用方面存在困难或限制,但人们越来越有兴趣应用 CRF 受体激动剂或拮抗剂来治疗炎症性疾病。本综述描述了 CRF 家族及其受体在炎症中的作用和机制;还将讨论 CRF 受体激动剂或拮抗剂在炎症性疾病或紊乱中的可能应用。

相似文献

1
Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?促肾上腺皮质激素释放因子家族及其受体:外周的促炎或抗炎靶点?
Inflamm Res. 2011 Aug;60(8):715-21. doi: 10.1007/s00011-011-0329-2. Epub 2011 Apr 8.
2
Corticotropin-releasing factor family and its receptors: tumor therapeutic targets?促肾上腺皮质激素释放因子家族及其受体:肿瘤治疗靶点?
Biochem Biophys Res Commun. 2007 Nov 3;362(4):785-8. doi: 10.1016/j.bbrc.2007.08.014. Epub 2007 Aug 29.
3
Cardiovascular functions of central corticotropin-releasing factor related peptides system.中枢促肾上腺皮质激素释放因子相关肽系统的心血管功能。
Neuropeptides. 2019 Jun;75:18-24. doi: 10.1016/j.npep.2019.03.006. Epub 2019 Mar 20.
4
The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory Response.促肾上腺皮质激素释放因子(CRF)神经肽家族及其受体在旁分泌/局部调节炎症反应中的多方面概况
Curr Mol Pharmacol. 2018;11(1):39-50. doi: 10.2174/1874467210666170109164430.
5
The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications.炎症中神经肽的促肾上腺皮质激素释放因子(CRF)家族:潜在的治疗应用
Curr Med Chem. 2005;12(13):1503-12. doi: 10.2174/0929867054039008.
6
Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.人促肾上腺皮质激素释放因子受体激动剂和拮抗剂结合域的定位
Mol Endocrinol. 1997 Dec;11(13):2048-53. doi: 10.1210/mend.11.13.0034.
7
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response.神经肽的CRF家族及其受体——中枢应激反应的介质
Curr Mol Pharmacol. 2018;11(1):4-31. doi: 10.2174/1874467210666170302104053.
8
Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.人心脏中尿皮质素和促肾上腺皮质激素释放因子受体亚型的表达
J Clin Endocrinol Metab. 2002 Jan;87(1):340-6. doi: 10.1210/jcem.87.1.8160.
9
Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.促肾上腺皮质激素释放因子(CRF)家族肽通过CRF受体1和2β对细胞外调节激酶1/2磷酸化的特异性及调控作用
Endocrinology. 2004 Apr;145(4):1718-29. doi: 10.1210/en.2003-1023. Epub 2003 Dec 11.
10
Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.将促肾上腺皮质激素释放因子受体特征化的放射性配体:激动剂尿皮质素和拮抗剂抗促肾上腺皮质激素释放因子的比较
J Pharmacol Exp Ther. 1999 Feb;288(2):729-34.

引用本文的文献

1
The expression and possible role of corticotropin-releasing hormone family peptides and their corresponding receptors in gynaecological malignancies and premalignant conditions: a systematic review.促肾上腺皮质激素释放激素家族肽及其相应受体在妇科恶性肿瘤和癌前病变中的表达及可能作用:一项系统综述
Prz Menopauzalny. 2023 Dec;22(4):227-235. doi: 10.5114/pm.2023.133878. Epub 2023 Dec 21.
2
The expression of corticotropin-releasing hormone family peptides in premalignant and malignant vulvar lesions.促肾上腺皮质激素释放激素家族肽在前恶性和恶性外阴病变中的表达。
Clin Transl Oncol. 2024 Jan;26(1):260-268. doi: 10.1007/s12094-023-03249-8. Epub 2023 Jun 29.
3

本文引用的文献

1
Urocortins in heart failure.尿皮质素在心力衰竭中的作用。
Biochem Pharmacol. 2010 Aug 1;80(3):289-96. doi: 10.1016/j.bcp.2010.03.032. Epub 2010 Apr 2.
2
Emerging role of alternative splicing of CRF1 receptor in CRF signaling.促肾上腺皮质激素释放因子1受体可变剪接在促肾上腺皮质激素释放因子信号传导中的新作用
Acta Biochim Pol. 2010;57(1):1-13. Epub 2010 Mar 16.
3
Histamine modulation of peripheral CRH receptor type 1alpha expression is dependent on Ca(2+) signalling and NF-kappaB/p65 transcriptional activity.组氨酸对外周 CRH 受体 1α 表达的调节依赖于 Ca(2+) 信号和 NF-κB/p65 转录活性。
Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs.
超越抑郁和焦虑;促肾上腺皮质激素释放激素拮抗剂在盆腔和腹部器官疾病中的作用的系统评价。
PLoS One. 2022 Mar 11;17(3):e0264909. doi: 10.1371/journal.pone.0264909. eCollection 2022.
4
Genetic Regulation of Immunoglobulin G Glycosylation.免疫球蛋白 G 糖基化的遗传调控。
Exp Suppl. 2021;112:259-287. doi: 10.1007/978-3-030-76912-3_8.
5
Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders.肾上腺外糖皮质激素生物合成:对自身免疫和炎症性疾病的影响。
Genes Immun. 2020 May;21(3):150-168. doi: 10.1038/s41435-020-0096-6. Epub 2020 Mar 23.
6
Corticotropin-releasing hormone improves survival in pneumococcal pneumonia by reducing pulmonary inflammation.促肾上腺皮质激素释放激素通过减轻肺部炎症改善肺炎球菌肺炎的生存率。
Physiol Rep. 2017 Jan;5(1). doi: 10.14814/phy2.13000.
7
Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.雄性大鼠结肠中的尿皮质素和2型促肾上腺皮质激素释放因子受体变体:基因表达、内毒素调节及抗炎作用
Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15;310(6):G387-98. doi: 10.1152/ajpgi.00337.2015. Epub 2016 Jan 7.
8
Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection.尿皮质素-2对p38丝裂原活化蛋白激酶信号通路的抑制作用是缺血性心脏保护的另一种机制。
Mol Cell Biochem. 2015 Jan;398(1-2):135-46. doi: 10.1007/s11010-014-2213-1. Epub 2014 Sep 23.
9
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.《2013/14药理学简明指南:G蛋白偶联受体》
Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445.
10
Key role of CRF in the skin stress response system.CRF 在皮肤应激反应系统中的关键作用。
Endocr Rev. 2013 Dec;34(6):827-84. doi: 10.1210/er.2012-1092. Epub 2013 Aug 12.
Mol Immunol. 2010 Apr;47(7-8):1426-37. doi: 10.1016/j.molimm.2010.02.012. Epub 2010 Mar 15.
4
Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.促肾上腺皮质激素释放激素家族肽调节肠道血管生成。
Gastroenterology. 2010 Jun;138(7):2457-67, 2467.e1-5. doi: 10.1053/j.gastro.2010.02.055. Epub 2010 Mar 3.
5
Extracellular matrix, inflammation, and the angiogenic response.细胞外基质、炎症与血管生成反应。
Cardiovasc Res. 2010 May 1;86(2):226-35. doi: 10.1093/cvr/cvq049. Epub 2010 Feb 12.
6
Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells.促肾上腺皮质激素释放因子受体 2 的激活抑制人小细胞肺癌细胞的生长。
Cancer Invest. 2010 Feb;28(2):146-55. doi: 10.3109/07357900903179617.
7
Local secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammation.尿皮质素 1 的局部分泌促进脂多糖诱导的炎症期间的微血管通透性。
Endocrinology. 2009 Dec;150(12):5428-37. doi: 10.1210/en.2009-0489. Epub 2009 Oct 9.
8
Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells.尿皮质素可增加白细胞介素-4和白细胞介素-10的分泌,并逆转脂多糖诱导的人滋养层原代细胞中肿瘤坏死因子-α的释放。
Am J Reprod Immunol. 2009 Oct;62(4):224-31. doi: 10.1111/j.1600-0897.2009.00729.x. Epub 2009 Aug 24.
9
Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.尿皮质素通过促皮质素释放因子 2 型受体在大鼠主动脉内皮细胞中诱导 COX-2 和 ICAM-1 的表达。
Br J Pharmacol. 2009 Oct;158(3):819-29. doi: 10.1111/j.1476-5381.2009.00346.x. Epub 2009 Aug 19.
10
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.尿皮质素通过促肾上腺皮质激素释放因子 1 型受体促进血栓闭塞性脉管炎大鼠模型血管炎的发展。
Br J Pharmacol. 2009 Aug;157(8):1368-79. doi: 10.1111/j.1476-5381.2009.00210.x. Epub 2009 Jun 30.